A case of sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis complicated by concurrent subacute thyroiditis

Sodium-glucose cotransporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus are gaining popularity due to their cardioprotective and renoprotective effects, yet SGLT2 inhibitors are increasingly associated with euglycemic diabetic ketoacidosis, which could be life-threatening if...

Full description

Bibliographic Details
Main Authors: Miyu Kinoshita, Koichiro Azuma, Tatsuo Yanagawa
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of Clinical and Translational Endocrinology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214624522000181